Home
Jagsonpal Pharmaceuticals Ltd Share Price History
Jagsonpal Pharmaceuticals Ltd
NSE : 03 Apr, 2025
233.535.7 (2.5%)
Prev Close
227.8
Open Price
227.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
128611
Today's High / Low
243.6 / 226.4
52 WK High / Low
328.0 / 110.0
Market Price of Jagsonpal Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Monitoring Jagsonpal Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | 145 |
| Sales YoY Gr. | - |
| Adj EPS | 4.53 |
| YoY Gr. | - |
| Net Profit (Cr.) | 12 |
| BVPS | 38.96 |
Key Financial Parameters
| Parameter | 2017 |
|---|---|
| Return on Capital Emp. % | 3.54 |
| Op. Profit Mgn % | 4.29 |
| Net Profit Mgn % | -0.65 |
| Debt to Equity % | 0.24 |
Latest Shareholding
Promoters Holdings Over Time
About Jagsonpal Pharmaceuticals Ltd
- Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana.
- The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs.
- Simultaneously, it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd. The company has a strategic alliance with Fidia Spa, Italy; and B Spofola, Czechoslovakia; to manufacture sophisticated drugs in India.
- It has tied up with another Israel-based company, Makhteshim Chemical Works, for acquiring the marketing rights of an anti-oxidant product.
- In 1994, the company has also promoted Aresco Financial Services, a new financial company.
Popular Search
FAQs for Jagsonpal Pharmaceuticals Ltd Share Price History
What are the key events that typically impact Jagsonpal Pharmaceuticals Ltd's share price history?
Key events that impact Jagsonpal Pharmaceuticals Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Jagsonpal Pharmaceuticals Ltd's share price history?
Stock splits reduce the nominal price of Jagsonpal Pharmaceuticals Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Jagsonpal Pharmaceuticals Ltd?
Dividends can influence Jagsonpal Pharmaceuticals Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Jagsonpal Pharmaceuticals Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Jagsonpal Pharmaceuticals Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Jagsonpal Pharmaceuticals Ltd’s share price history?
To understand Jagsonpal Pharmaceuticals Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
